振荡正压呼气治疗在慢阻肺中的随机对照试验
本研究纳入122例每日或多数日咳痰的稳定期慢阻肺患者,随机分为Acapella装置治疗组与常规护理组,评估3个月后咳嗽相关生活质量。结果显示OPEP治疗改善LCQ、FACIT和EQ-5D评分,并减少24小时咳嗽频率,但对睡眠 disturbance 无显著影响。
要点
- OPEP治疗可改善每日咳痰慢阻肺患者的咳嗽相关生活质量。
- OPEP治疗可减少24小时咳嗽频率,并改善疲劳和一般生活质量。
- OPEP对睡眠 disturbance 无统计学显著效果。
核心结论
- 规律使用Acapella装置可改善每日或多数日咳痰的慢阻肺患者的症状和生活质量。
研究设计与样本
- 评估者盲、平行组随机对照试验,比较3个月Acapella装置与常规护理(包括主动循环呼吸技术)。
- 纳入122例稳定期慢阻肺患者(OPEP组61例,对照组61例),40%女性,17%吸烟者,FEV1占预计值38(25-56)%,年龄62±10岁。
- 103例完成研究(OPEP组55例,对照组48例)。
- 子研究(n=45)进行咳嗽和睡眠 disturbance/运动的客观监测。
主要发现
- LCQ改善:均差(95%CI)1.03(0.71至2.10),p=0.03。
- FACIT评分改善:4.68(1.34至8.02),p<0.001。
- EQ-5D改善:4.00(0.49至19.75),p=0.04。
- 咳嗽频率改善:-60(-43至-95)次/24小时,p<0.001。
- 睡眠 disturbance 无统计学显著效果。
临床怎么用
- 对于每日或多数日咳痰的稳定期慢阻肺患者,可考虑规律使用Acapella装置以改善咳嗽相关生活质量和减少咳嗽频率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oscillatory positive expiratory pressure (OPEP) devices are intended to facilitate sputum clearance and reduce cough, but there is limited evidence for their effectiveness in COPD, or to guide patient selection. We aimed to assess the impact of OPEP therapy on quality of life and objective measures of cough and sleep disturbance in patients with COPD with regular sputum production. METHODS: We enrolled stable patients with COPD, who reported sputum production every day or most days, into an assessor-blind, parallel-group, randomised controlled trial comparing 3 months of using an Acapella device against usual care (including use of the active cycle of breathing technique). The primary outcome was cough-related quality of life measured using the Leicester Cough Questionnaire (LCQ). Secondary outcomes included fatigue (Functional Assessment of Chronic Illness Therapy, FACIT score) and generic quality of life (EuroQol-5 Dimensions, EQ-5D). In a substudy (n=45), objective monitoring of cough and disturbance/movement during sleep were also available. RESULTS: 122 participants (61/61 OPEP/control) were recruited, 40% female, 17% smokers, FEV1 38 (25-56)% predicted, and age 62±10 years. 103 completed the study (55/48 OPEP/control). Use of OPEP was associated with an improvement in LCQ compared with controls; MD (95% CI) 1.03 (0.71 to 2.10); (p=0.03), FACIT score 4.68 (1.34 to 8.02); (p<0.001) and EQ-5D 4.00 (0.49 to 19.75); (p=0.04). There was also an improvement in cough frequency -60 (-43 to -95) coughs/24 hours (p<0.001), but no statistically significant effect on sleep disturbance was identified. CONCLUSIONS: Regular use of an Acapella device improves symptoms and quality of life in people with COPD who produce sputum daily or most days. TRIAL REGISTRATION NUMBER: ISRCTN44651852.
引用
- Alghamdi SM, Alsulayyim AS, Alasmari AM, et al. Oscillatory positive expiratory pressure therapy in COPD (O-COPD): a randomised controlled trial. Thorax. 2022. PMID: 35948418. doi:10.1136/thorax-2022-219077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。